Hysteroscopic management of displaced levonorgestrel-releasing intrauterine system

Journal of Obstetrics and Gynaecology Research

Volumn 39, Issue 5, 2013, Pages 1014-1018

  Kuzel, David ^a   Hrazdirova, Lucie ^a   Kubinova, Kristyna ^a   Dundr, Pavel ^a   Cibula, David ^a   Mara, Michal ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Abnormal uterine bleeding; Hysteroscopy; Irregular uterine bleeding; Levonorgestrel releasing intrauterine system; Pelvic pain

Indexed keywords

LEVONORGESTREL;

ADULT; AMENORRHEA; ARTICLE; CLINICAL EFFECTIVENESS; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; HYSTEROSCOPE; HYSTEROSCOPY; MAJOR CLINICAL STUDY; PELVIS PAIN SYNDROME; PREOPERATIVE EVALUATION; SPOTTING; UTERUS BLEEDING;

ADULT; COHORT STUDIES; DEVICE REMOVAL; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTEROSCOPY; INTRAUTERINE DEVICE MIGRATION; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; METRORRHAGIA; MIDDLE AGED; PELVIC PAIN; YOUNG ADULT;

EID: 84880290141     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/jog.12007     Document Type: Article

References (14)

1. United Nations. World Contraceptive Use 2007. New York: United Nations Publications, 2007.
2. Bayer HealthCare pharmaceuticals, Mirena Physician Prescribing Information, 2008. Available from URL: http://www.accessdata.fda.gov/drugsatfda- docs/label/2008/021225s019lbl.pdf
3. Fraser IS, Critchley HO, Munro MG. Abnormal uterine bleeding: Getting our terminology straight. Curr Opin Obstet Gynecol 2007; 19: 591-595.
4. Rönnerdag M, Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. Acta Obstet Gynecol Scand 1999; 78: 716-721.
5. Nilsson CG, Luukkainen T, Diaz J, Allonen H. Clinical performance of a new levonorgestrel-releasing intrauterine device. A randomized comparison with a nova-T-copper device. Contraception 1982; 25: 345-356.
6. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: A randomized comparative trial. Contraception 1994; 49: 56-72.
7. Hidalgo M, Bahamondes L, Perrotti M, Diaz J, Dantas-Monteiro C, Petta C. Bleeding patterns and clinical performance of the levonogestrel-releasing intrauterine system (Mirena) up to two years. Contraception 2002; 65: 129-132.
8. Bastianelli C, Farris M, Rapiti S. Mirena, an Italian experience. Minerva Ginecol 2011; 63: 343-349.
9. Jensen JT, Nelson AL, Costales AC. Subject and clinician experience with the levonorgestrel-releasing intrauterine system. Contraception 2008; 77: 22-29.
10. Daud S, Ewies AA. Levonorgestrel-releasing intrauterine system: Why do some women dislike it?. Gynecol Endocrinol 2008; 24: 686-690.
11. Zhang J, Feldblum PJ, Chi IC, Farr MG. Risk factors for copper T IUD expulsion: An epidemiologic analysis. Contraception 1992; 46: 427-433.
12. Shimoni N. Intrauterine contraceptives:Areview of uses, side effects, and candidates. Semin Reprod Med 2010; 28: 118-125.
13. Wildemeersch D, Andrade A. Review of clinical experience with the frameless LNG-IUS for contraception and treatment of heavy menstrual bleeding. Gynecol Endocrinol 2010; 26: 383-389.
14. Bettocchi S, Nappi L, Ceci O, Selvaggi L. Office hysteroscopy. Obstet Gynecol Clin North Am 2004; 31: 641-654.